MedPath

To compare the safety, efficacy and outcome of using Phenobarbitone and Levetiracetam in neonatal convulsions

Not Applicable
Conditions
Health Condition 1: G09- Sequelae of inflammatory diseasesof central nervous system
Registration Number
CTRI/2024/08/072048
Lead Sponsor
RNT MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)EEG confirmed seizure in all Term and Pre-term babies admitted in NICU

2)Those patients whose guardian has given informed consent.

Exclusion Criteria

1) Neonates with electrolyte imbalance ( Hyponatremia and Hypernatremia)

2)Hypoglycemia

3)Hypocalcemia

4) Hypomagnesemia

5)Any previous history of receiving ASM

• Family history of any seizure disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath